[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Pages 14954-14955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07232]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions; Availability for Licensing
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. to achieve
expeditious commercialization of results of federally-funded research
and development.
FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained
by emailing the indicated licensing contact at the National Heart,
Lung, and Blood, Office of Technology Transfer and Development Office
of Technology Transfer, 31 Center Drive, Room 4A29, MSC2479, Bethesda,
MD 20892-2479; telephone: 301-402-5579. A signed Confidential
Disclosure Agreement may be required to receive any unpublished
information.
SUPPLEMENTARY INFORMATION: Technology description follows.
Medical Device for Vascular Dilation
A vascular dilator is commonly used in transcatheter cardiovascular
intervention procedures. Commercially available vascular dilators have
introducer sheaths with a finite thickness and mismatched diameter with
the dilators. This causes uneven stretching of the trailing edge of the
sheath and severe damage to the target vessels. This technology
produces the specialized sheath with a shoulder that can be introduced
percutaneously with an enhanced dilator into a broad range of diseased
target vessels and chambers with reduced vascular injury. The shoulder
helps to match the diameter of the introducer sheath so that there is a
smooth transition between the dilator and the introducer sheath. The
invention allows the dilator to be withdrawn in segments without
disrupting the introducer sheath.
[[Page 14955]]
Development Stage: Reduces vascular injury while using large-bore
introducer sheaths in interventional cardiac procedures:
Transcatheter aortic valve replacement
Direct transthoracic access into the heart muscle for endografts
Inventors: Dr. Robert Lederman (NHLBI), Dr. Ozgur Kocaturk (NHLBI),
Dr. Adam Greenbaum (Henry Ford Hospital).
Intellectual Property: HHS Reference No. E-759-2013/0; U.S
Provisional Patent Application 61/890,961 filed October 15, 2013,
International Patent Application PCT/US2014/060270 filed October 13,
2014, U.S. Patent Application 15/025,336 filed March 28, 2016, European
Patent 3057646 validated in Switzerland, Germany, France, the United
Kingdom, and Ireland.
Licensing Contact: Michael Shmilovich, Esq., CLP; 301-435-5019;
[email protected].
Dated: April 4, 2019.
Michael A. Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood
Institute, Office of Technology Transfer and Development.
[FR Doc. 2019-07232 Filed 4-11-19; 8:45 am]
BILLING CODE 4140-01-P